These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats. Zhang X; Tajima K; Kageyama K; Kyoi T World J Gastroenterol; 2008 Aug; 14(30):4784-90. PubMed ID: 18720540 [TBL] [Abstract][Full Text] [Related]
3. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model. Zhang YS; Li Y; Wang Y; Sun SY; Jiang T; Li C; Cui SX; Qu XJ J Cancer Res Clin Oncol; 2016 May; 142(5):913-25. PubMed ID: 26702935 [TBL] [Abstract][Full Text] [Related]
4. Irsogladine maleate counters the interleukin-1 beta-induced suppression in gap-junctional intercellular communication but does not affect the interleukin-1 beta-induced zonula occludens protein-1 levels in human gingival epithelial cells. Fujita T; Ashikaga A; Shiba H; Kajiya M; Kishimoto A; Hirata R; Tsunekuni N; Hirono C; Kawaguchi H; Shiba Y; Kurihara H J Periodontal Res; 2008 Feb; 43(1):96-102. PubMed ID: 18230110 [TBL] [Abstract][Full Text] [Related]
5. Irsogladine, an anti-ulcer drug, suppresses superoxide production by inhibiting phosphodiesterase type 4 in human neutrophils. Kyoi T; Noda K; Oka M; Ukai Y Life Sci; 2004 Nov; 76(1):71-83. PubMed ID: 15501481 [TBL] [Abstract][Full Text] [Related]
6. Irsogladine Maleate Prevents Colitis in Interleukin-10 Gene-Deficient Mice by Reducing Interleukin-12 and -23 Production. Nakagawa T; Katsuno T; Noguchi Y; Mandai Y; Yoshihama S; Saito K; Maruoka D; Matsumura T; Arai M; Yokosuka O Biol Pharm Bull; 2015; 38(11):1681-8. PubMed ID: 26521820 [TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor-1 (Pai-1) blockers suppress intestinal polyp formation in Min mice. Mutoh M; Niho N; Komiya M; Takahashi M; Ohtsubo R; Nakatogawa K; Ueda K; Sugimura T; Wakabayashi K Carcinogenesis; 2008 Apr; 29(4):824-9. PubMed ID: 18258607 [TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice. Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta. Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006 [TBL] [Abstract][Full Text] [Related]
10. Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin/+ mice. Barone M; Tanzi S; Lofano K; Scavo MP; Pricci M; Demarinis L; Papagni S; Guido R; Maiorano E; Ingravallo G; Comelli MC; Francavilla A; Di Leo A Carcinogenesis; 2010 Feb; 31(2):269-74. PubMed ID: 19945967 [TBL] [Abstract][Full Text] [Related]
11. Impact of Acetazolamide, a Carbonic Anhydrase Inhibitor, on the Development of Intestinal Polyps in Min Mice. Noma N; Fujii G; Miyamoto S; Komiya M; Nakanishi R; Shimura M; Tanuma SI; Mutoh M Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420165 [TBL] [Abstract][Full Text] [Related]
12. Irsogladine prevents monochloramine-induced gastric mucosal lesions by improving the decrease in mucosal blood flow due to the disturbance of nitric oxide synthesis in rats. Kyoi T; Oka M; Noda K; Ukai Y J Pharmacol Sci; 2003 Nov; 93(3):314-20. PubMed ID: 14646249 [TBL] [Abstract][Full Text] [Related]
13. Olive oil and omega-3 polyunsaturated fatty acids suppress intestinal polyp growth by modulating the apoptotic process in ApcMin/+ mice. Barone M; Notarnicola M; Caruso MG; Scavo MP; Viggiani MT; Tutino V; Polimeno L; Pesetti B; Di Leo A; Francavilla A Carcinogenesis; 2014 Jul; 35(7):1613-9. PubMed ID: 24632492 [TBL] [Abstract][Full Text] [Related]
14. Changes in cyclic AMP content of rat gastric mucosa induced by ulcerogenic stimuli--in relation to the antiulcer activity of irsogladine maleate. Ueda F; Watanabe M; Hirata Y; Kyoi T; Kimura K Jpn J Pharmacol; 1991 Apr; 55(4):493-9. PubMed ID: 1653374 [TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor. Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490 [TBL] [Abstract][Full Text] [Related]
16. Improved innate immune responses by Frondanol A5, a sea cucumber extract, prevent intestinal tumorigenesis. Janakiram NB; Mohammed A; Bryant T; Lightfoot S; Collin PD; Steele VE; Rao CV Cancer Prev Res (Phila); 2015 Apr; 8(4):327-37. PubMed ID: 25657017 [TBL] [Abstract][Full Text] [Related]
17. Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice. Kuno T; Hatano Y; Tomita H; Hara A; Hirose Y; Hirata A; Mori H; Terasaki M; Masuda S; Tanaka T Carcinogenesis; 2013 Feb; 34(2):361-9. PubMed ID: 23125223 [TBL] [Abstract][Full Text] [Related]
18. The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice. Mochida Y; Taguchi K; Taniguchi S; Tsuneyoshi M; Kuwano H; Tsuzuki T; Kuwano M; Wada M Carcinogenesis; 2003 Jul; 24(7):1219-24. PubMed ID: 12807720 [TBL] [Abstract][Full Text] [Related]
19. Irsogladine maleate may preserve gastric mucosal hydrophobicity against ethanol in phospholipids independent way in rats. Tatsumi Y; Tanino M; Kodama T; Kashima K; Katsura M; Okuma S Jpn J Pharmacol; 1998 Aug; 77(4):293-9. PubMed ID: 9749930 [TBL] [Abstract][Full Text] [Related]
20. The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac. Wang X; Kingsley PJ; Marnett LJ; Eling TE Cancer Prev Res (Phila); 2011 Jan; 4(1):150-60. PubMed ID: 21205743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]